Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
24.08
+0.23 (0.96%)
Mar 18, 2026, 4:00 PM EDT - Market closed

Pelthos Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
784----
Enterprise Value
675----
Last Close Price
24.086.41----
PB Ratio
1.28-1.42----
Debt / Equity Ratio
0.06-0.80-0.20-0.15-0.30-0.07
Net Debt / Equity Ratio
-0.18-0.62-0.18-0.13-0.30-0.07
Net Debt / EBITDA Ratio
----0.30--
Quick Ratio
0.900.130.020.02--
Current Ratio
2.010.340.020.02-0.02
Return on Assets (ROA)
-20.64%-645.79%-5663.30%---
Return on Capital Employed (ROCE)
-20.90%279.00%106.50%62.50%32.50%37.80%
Earnings Yield
-30.27%-205.89%----
Buyback Yield / Dilution
-170.72%-336.69%-193.25%---
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q